184216

Loading viewer...

presentation

Format: PDF presentation

This presentation outlines the topline results from a Phase 1/2 study evaluating the safety and efficacy of Trappsol® Cyclo™ for Niemann-Pick Type C1 Disease.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Cyclo Therapeutics

View all →

report

report

Similar presentations from other companies

Browse all →

presentation

Nokian Tyres

Mirati-Corporate-Deck_May-2023-Final-5_8

presentation

Mirati Therapeutics